Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryan S. Monahan
Observed names:
R Monahan,
R.S. Monahan,
Ryan Monahan,
Ryan S Monahan
Observed institutions:
Washington University in St. Louis,
Cancer Consortium,
Alvin J. Siteman Cancer Center
OpenAlex ID:
A5010452265
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
2020
·
Nicole M Kuderer
, Toni K Choueiri
, et al.
·
The Lancet
·
1,726
PDF
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
2021
·
Michael A. Thompson
, Jeffrey P. Henderson
, et al.
·
JAMA Oncology
·
192
PDF
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
2022
·
Julie Fu
, Sonya A. Reid
, et al.
·
JAMA Network Open
·
66
PDF
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
2022
·
Ziad Bakouny
, Chris Labaki
, et al.
·
JAMA Oncology
·
54
PDF
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G‐CSF
2009
·
Mike G. Martin
, Kristan M. Augustin
, et al.
·
American Journal of Hematology
·
50
PDF
Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis
2009
·
Timothy A. Graubert
, Michelle A. Payton
, et al.
·
PLoS ONE
·
50
PDF
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML
2012
·
G Ramsingh
, P Westervelt
, et al.
·
Leukemia
·
42
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
2021
·
Andrew L. Schmidt
, Matthew D. Tucker
, et al.
·
JAMA Network Open
·
38
PDF
Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma
2009
·
Julie O'Neal
, Feng Gao
, et al.
·
Experimental Hematology
·
32
PDF
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
2020
·
Maheen Abidi
, David M. Aboulafia
, et al.
·
Cancer Cell
·
31
PDF
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
2023
·
Shuchi Gulati
, Chih-Yuan Hsu
, et al.
·
JAMA Oncology
·
10
PDF
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
2022
·
Jessica E. Hawley
, Tianyi Sun
, et al.
·
JAMA Network Open
·
10
PDF
Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trial
2025
·
Kelly Bolton
, Yazan Madanat
, et al.
·
Blood
·
2
PDF
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
2023
·
Douglas B. Johnson
, Michael B. Atkins
, et al.
·
BMC Cancer
·
2
PDF
A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,
2011
·
Giridharan Ramsingh
, Peter Westervelt
, et al.
·
Blood
·
1
Comprehensive Genomic Copy Number and Sequence Analysis of 28 Chromosome 5q31.2 Candidate Genes in De Novo MDS.
2007
·
Timothy A. Graubert
, M.A. Payton
, et al.
·
Blood
·
1
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium
2026
·
Alaina J. Brown
, Chih-Yuan Hsu
, et al.
·
JCO oncology advances.
IDH1/2-mutant clonal hematopoiesis: A novel driver of autoinflammatory disease
2025
·
Griffen Mustion
, Flore Castellan
, et al.
·
Blood
PDF
Coordinate Interstitial Deletion of Retinoblastoma (RB1) and Neurobeachin (NBEA) Is a Recurring Event in Multiple Myeloma.
2007
·
Julie O’Neal
, AnnaLynn Molitoris
, et al.
·
Blood
Show more works
View as search
Works count:
19
Citation count:
2,307
H-index:
10
I10-index:
12
Year
Topic
Type